SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
212.50    0.00 (0.00%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £145.08m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Scrip Dividend Reference Price

12 Jun 2026 07:00

RNS Number : 0127I
Helios Underwriting Plc
12 June 2026
 

12 June 2026

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Scrip Dividend Reference Price

 

Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, announces that the scrip dividend reference price for the fully paid ordinary shares to be issued to shareholders electing to receive the scrip dividend alternative for the total dividend of 7.0p per share and the special dividend of 3.0p per share for the year ended 31 December 2025 will be 214.1p per share.

 

The scrip reference price is calculated as the average of the Company's closing middle market share price for the five consecutive dealing days commencing on the ex-dividend date of 4 June 2026.

 

The timetable for the proposed scrip dividend, which remains subject to approval at the Company's Annual General Meeting to be held on 22 June 2026, is as follows:

 

26 June 2026

Final date for receipt of Scrip Dividend Mandate Election forms and CREST Dividend Election Input Messages

10 July 2026

Allotment of New Shares to Certificated and CREST Shareholders and admission for trading

 

 

For further information, please contact:

Helios Underwriting plc

Louis Tucker - Chief Executive Officer +44 (0)20 3965 6441 

Adhiraj Maitra - Director of Finance and Operations +44 (0)20 3743 2114

 

Peel Hunt (Nomad, Broker and Financial Adviser)

Dan Webster / Andrew Buchanan / Martin Frowde +44 (0) 20 7418 8900

 

Singer Capital Markets (Joint Broker)

Charles Leigh-Pemberton / Russell Cook / James Todd   +44 (0)20 7496 3000

 

FTI Consulting

Ed Berry +44 (0)7703 330 199

Christian Harte +44 (0)7974 288 763

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAKKFFEPKEFA
Date   Source Headline
29th Aug 202312:30 pmRNSTransaction in Own Shares
25th Aug 20232:12 pmRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in own shares
23rd Aug 202311:44 amRNSShare Repurchase Programme
21st Aug 20234:23 pmRNSNotification of Major Holdings
21st Aug 202311:40 amRNSDirector's Shareholding
18th Aug 20238:22 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20234:30 pmRNSShare Repurchase Programme
2nd Aug 20237:00 amRNSTotal Voting Rights
25th Jul 20237:00 amRNSAcquisition
14th Jul 20237:00 amRNSDirector Dealing
14th Jul 20237:00 amRNSAcquisition of Limited Liability Vehicle
13th Jul 20237:00 amRNSIssue of Equity
4th Jul 20237:00 amRNSResults of Scrip Dividend Election
29th Jun 20233:46 pmRNSDirectorship Change
29th Jun 202311:27 amRNSResults of Annual General Meeting
29th Jun 20237:00 amRNSNotification of Major Holdings
16th Jun 20237:00 amRNSScrip Dividend Reference Price
7th Jun 20233:53 pmRNSDirector’s Shareholding
5th Jun 20233:39 pmRNSFinal Dividend Timetable
5th Jun 20237:00 amRNSDirector’s/PCA Shareholdings
1st Jun 20237:00 amRNSGrant of LTIP Award
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
31st May 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
26th May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSChange of Adviser
11th May 20237:00 amRNSDirectors' Disclosure
11th Apr 20237:00 amRNSDirector's/PCAs' Shareholding
5th Apr 20237:00 amRNSGrant of LTIP Award and Director Dealing
5th Apr 20237:00 amRNSDirector/PCA Shareholdings
4th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSQuarterly Syndicate Mid Point Forecasts
10th Jan 20237:00 amRNS2023 Helios Retained Capacity Update
29th Dec 20223:38 pmRNSAcquisitions of LLVs, Issue of Equity and TVR
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 202212:06 pmRNSHolding(s) in Company
19th Dec 20229:07 amRNSGrant of LTIP Awards and Directors' Dealings
14th Dec 202212:47 pmRNSHolding(s) in Company
13th Dec 202211:29 amRNSResult of GM, TVR and Directors' Participation
12th Dec 20227:00 amRNSResult of Open Offer
24th Nov 202212:54 pmRNSReplacement - Result of Placing and Subscription
24th Nov 20227:00 amRNSResult of Placing and Subscription
23rd Nov 20224:45 pmRNSFundraising to raise up to approximately £13.5m
29th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSQuarterly Syndicate Mid Point Forecasts
29th Jun 20221:13 pmRNSResult of AGM
1st Jun 20222:31 pmRNSPosting of Annual Report and Notice of AGM
27th May 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.